These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rheological Properties of Cystic Fibrosis Bronchial Secretion and in Vitro Drug Permeation Study: The Effect of Sodium Bicarbonate. Stigliani M; Manniello MD; Zegarra-Moran O; Galietta L; Minicucci L; Casciaro R; Garofalo E; Incarnato L; Aquino RP; Del Gaudio P; Russo P J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):337-45. PubMed ID: 26741302 [TBL] [Abstract][Full Text] [Related]
3. Physical and functional properties of airway secretions in cystic fibrosis--therapeutic approaches. Puchelle E; de Bentzmann S; Zahm JM Respiration; 1995; 62 Suppl 1():2-12. PubMed ID: 7792436 [TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis sputum: a barrier to the transport of nanospheres. Sanders NN; De Smedt SC; Van Rompaey E; Simoens P; De Baets F; Demeester J Am J Respir Crit Care Med; 2000 Nov; 162(5):1905-11. PubMed ID: 11069833 [TBL] [Abstract][Full Text] [Related]
5. Gentamicin and leucine inhalable powder: what about antipseudomonal activity and permeation through cystic fibrosis mucus? Russo P; Stigliani M; Prota L; Auriemma G; Crescenzi C; Porta A; Aquino RP Int J Pharm; 2013 Jan; 440(2):250-5. PubMed ID: 22683456 [TBL] [Abstract][Full Text] [Related]
6. Mucous solids and liquid secretion by airways: studies with normal pig, cystic fibrosis human, and non-cystic fibrosis human bronchi. Martens CJ; Inglis SK; Valentine VG; Garrison J; Conner GE; Ballard ST Am J Physiol Lung Cell Mol Physiol; 2011 Aug; 301(2):L236-46. PubMed ID: 21622844 [TBL] [Abstract][Full Text] [Related]
7. MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. Henke MO; Renner A; Huber RM; Seeds MC; Rubin BK Am J Respir Cell Mol Biol; 2004 Jul; 31(1):86-91. PubMed ID: 14988081 [TBL] [Abstract][Full Text] [Related]
8. The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum. Lethem MI; James SL; Marriott C Am Rev Respir Dis; 1990 Nov; 142(5):1053-8. PubMed ID: 2240828 [TBL] [Abstract][Full Text] [Related]
9. Is cystic fibrosis mucus abnormal? King M Pediatr Res; 1981 Feb; 15(2):120-2. PubMed ID: 7254936 [TBL] [Abstract][Full Text] [Related]
11. Delivery of photosensitisers and light through mucus: investigations into the potential use of photodynamic therapy for treatment of Pseudomonas aeruginosa cystic fibrosis pulmonary infection. Donnelly RF; McCarron PA; Cassidy CM; Elborn JS; Tunney MM J Control Release; 2007 Feb; 117(2):217-26. PubMed ID: 17196290 [TBL] [Abstract][Full Text] [Related]
12. Effect of normal and cystic fibrotic serum on ion transport and mucus glycoprotein secretion from the isolated rabbit trachea. Moriarty CM; Garett JS; Fontaine M J Med; 1982; 13(4):257-74. PubMed ID: 6957526 [TBL] [Abstract][Full Text] [Related]
13. Mucus-penetrating solid lipid nanoparticles for the treatment of cystic fibrosis: Proof of concept, challenges and pitfalls. Nafee N; Forier K; Braeckmans K; Schneider M Eur J Pharm Biopharm; 2018 Mar; 124():125-137. PubMed ID: 29291931 [TBL] [Abstract][Full Text] [Related]
14. Effect of covalently bound fatty acids and associated lipids on the viscosity of gastric mucus glycoprotein in cystic fibrosis. Slomiany BL; Murty VL; Carter SR; Slomiany A Digestion; 1986; 34(4):275-80. PubMed ID: 2427379 [TBL] [Abstract][Full Text] [Related]
15. Mucociliary Transport in Healthy and Cystic Fibrosis Pig Airways. Xie Y; Ostedgaard L; Abou Alaiwa MH; Lu L; Fischer AJ; Stoltz DA Ann Am Thorac Soc; 2018 Nov; 15(Suppl 3):S171-S176. PubMed ID: 30431346 [TBL] [Abstract][Full Text] [Related]
16. Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport. Dawson M; Wirtz D; Hanes J J Biol Chem; 2003 Dec; 278(50):50393-401. PubMed ID: 13679362 [TBL] [Abstract][Full Text] [Related]
17. A New Class of Safe Oligosaccharide Polymer Therapy To Modify the Mucus Barrier of Chronic Respiratory Disease. Pritchard MF; Powell LC; Menzies GE; Lewis PD; Hawkins K; Wright C; Doull I; Walsh TR; Onsøyen E; Dessen A; Myrvold R; Rye PD; Myrset AH; Stevens HN; Hodges LA; MacGregor G; Neilly JB; Hill KE; Thomas DW Mol Pharm; 2016 Mar; 13(3):863-72. PubMed ID: 26833139 [TBL] [Abstract][Full Text] [Related]
18. Disassembling the complexity of mucus barriers to develop a fast screening tool for early drug discovery. Pacheco DP; Butnarasu CS; Briatico Vangosa F; Pastorino L; Visai L; Visentin S; Petrini P J Mater Chem B; 2019 Aug; 7(32):4940-4952. PubMed ID: 31411620 [TBL] [Abstract][Full Text] [Related]
19. Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis. Bush A; Payne D; Pike S; Jenkins G; Henke MO; Rubin BK Chest; 2006 Jan; 129(1):118-23. PubMed ID: 16424421 [TBL] [Abstract][Full Text] [Related]
20. Mucus glycoproteins secreted by respiratory epithelial tissue from cystic fibrosis patients. Frates RC; Kaizu TT; Last JA Pediatr Res; 1983 Jan; 17(1):30-4. PubMed ID: 6835712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]